PCSK9 and metabolic dysfunction-associated steatotic liver disease: In the NAFLD as well as non-NAFLD, patient associations between PCSK9 and total cholesterol, triglycerides, cholesterol LDL-C, sLDLr, apo B100, apo A1, PTX3, and FLI were found.